drugset / Trial / NCT07305779
A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the effect of cytochrome P450 isoenzyme 2D6 (CYP2D6) inhibition by quinidine on the pharmacokinetic (PK) parameters of a single dose SEP-380135 in healthy adult participants.
Timeline
- Start
- 2025-03-07
- Primary completion
- 2025-05-03
- Completion
- 2025-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quinidine | Small molecule | — | Oral |
| Subject | SEP-380135 | Unknown | — | Oral |